Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
Rhea-AI Summary
Aurora Spine (OTCQB: ASAPF) will file its Q1 fiscal 2026 financial results for the period ended March 31, 2026, with SEDAR after market hours on May 27, 2026, and release a detailed earnings press release the morning of May 28, 2026.
Management will host an investor conference call on May 28, 2026, at 10:00 a.m. ET / 7:00 a.m. PT, with live webcast and replay options. Aurora Spine will also present and hold one-on-one investor meetings at the virtual Lytham Partners Spring 2026 Investor Conference on May 28, 2026.
Positive
- None.
Negative
- None.
News Market Reaction – ASAPF
In the May 27 session, ASAPF declined 2.67%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Company to Participate in the Lytham Partners Spring 2026 Investor Conference -
CARLSBAD, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced it will file its financial results with SEDAR for its first quarter of fiscal year 2026 for the period ended March 31, 2026, on Wednesday, May 27, 2026, after market hours. The company will issue a press release reviewing its financial results for the first quarter on the morning of May 28, 2026 before market trading. Later that morning, management will host a conference call for investors at 10:00 am ET/7:00am PT to discuss the results.
First Quarter of Fiscal Year 2026 Conference Call Details
Date and Time: Thursday, May 28, 2026, at 10:00 a.m. ET / 7:00 a.m. PT
Call-in Information: Interested parties can access the conference call by dialing (844) 861-5497 or (412) 317-5794.
Webcast: Interested parties can access the conference call via a live webcast, which is available via the following link: https://app.webinar.net/4o06MGEjw1p.
Replay: A teleconference replay of the call will be available until June 4, 2026, at (855) 669-9658 or (412) 317-0088, replay access code 8971699. Additionally, a replay of the webcast will be available at https://app.webinar.net/4o06MGEjw1p for 90 days.
Company to Participate in the Lytham Partners Spring 2026 Investor Conference
Aurora Spine will also participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.
Company Webcast
The webcast presentation will take place at 12:15 p.m. ET on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2026/ or directly at https://app.webinar.net/aBE8nL5zRmg. The webcast will also be available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/spring2026invreg/.
About Aurora Spine
Aurora Spine Corporation (TSX Venture: ASG | OTCQB: ASAPF) is an innovative designer and manufacturer of minimally invasive spinal implants and interventional pain management technologies. Headquartered in Carlsbad, California, the company’s mission is to improve spinal surgery outcomes through simplified, integrated, and cost-effective solutions that advance patient care worldwide. Additional information can be accessed at www.aurora-spine.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
Investor Contact
Adam Lowensteiner
Lytham Partners
(646) 829-9702
asapf@lythampartners.com
